CFTR and cystic fibrosis: In 2008, the CF foundation listed a total of 33 drugs in the development pipeline, of which approximately four targeted CFTR for potentiation of its function or placement in the plasma membrane.61 These incipient corrector and potentiator drugs were emerging as putative therapies and most of the initial research centered around the potentiation of G551D CFTR.